Citation Impact
Citing Papers
Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases
2011 Standout
Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy
2008
Calorie Restriction Promotes Mammalian Cell Survival by Inducing the SIRT1 Deacetylase
2004 StandoutScience
Protein Expression Profiling Identifies Subclasses of Breast Cancer and Predicts Prognosis
2005
Extension of Murine Life Span by Overexpression of Catalase Targeted to Mitochondria
2005 StandoutScience
Broad role for YBX1 in defining the small noncoding RNA composition of exosomes
2017 Nobel
Rictor and Integrin-Linked Kinase Interact and Regulate Akt Phosphorylation and Cancer Cell Survival
2008
Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation
2013 StandoutScience
Regulation of phosphoinositide 3-kinase expression in health and disease
2009
miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapy
2017
Expression and function of the insulin receptor substrate proteins in cancer
2009
Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
2007
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
2004 Standout
Identification of the Interaction Site within Acyl-CoA:Cholesterol Acyltransferase 2 for the Isoform-specific Inhibitor Pyripyropene A
2008 StandoutNobel
Role of insulin-like growth factor 1 receptor signalling in cancer
2005
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Triple-Negative Breast Cancer
2010 Standout
The translational landscape of mTOR signalling steers cancer initiation and metastasis
2012 Nature
Breast cancer stem cells: treatment resistance and therapeutic opportunities
2011
Inflammation and cancer
2002 StandoutNature
IDH1andIDH2Mutations in Gliomas
2009 Standout
MYC on the Path to Cancer
2012 Standout
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
2011
Physical Principles of Membrane Shape Regulation by the Glycocalyx
2019 StandoutNobel
Y-box factor YB1 controls p53 apoptotic function
2005
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogs
2002
The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
2009
Profiling the Breast Cancer Proteome — The New Tool of the Future?
2006
Long‐term effects of calorie or protein restriction on serum IGF‐1 and IGFBP‐3 concentration in humans
2008
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
Coordinate Expression of Colony-Stimulating Factor-1 and Colony-Stimulating Factor-1-Related Proteins Is Associated with Poor Prognosis in Gynecological and Nongynecological Leiomyosarcoma
2009
Impact of Insulin-Like Growth Factor Receptor-I Function on Angiogenesis, Growth, and Metastasis of Colon Cancer
2002
MicroRNA-148a deficiency promotes hepatic lipid metabolism and hepatocarcinogenesis in mice
2017
Uterine-specific p53 deficiency confers premature uterine senescence and promotes preterm birth in mice
2010
Lung Cancer, Cardiopulmonary Mortality, and Long-term Exposure to Fine Particulate Air Pollution
2002 Standout
Do Cancer Cells Care If Their Host Is Hungry?
2009
Insulin analogues and cancer risk: cause for concern orcause célèbre?
2010
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
2009 StandoutNature
Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
2004 Standout
Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions
2008
Insulin-Like Growth Factor 1 and Prostate Cancer Risk: A Population-Based, Case-Control Study
1998
Insulin-like Growth Factor 1 Induces Hypoxia-inducible Factor 1-mediated Vascular Endothelial Growth Factor Expression, Which is Dependent on MAP Kinase and Phosphatidylinositol 3-Kinase Signaling in Colon Cancer Cells
2002 StandoutNobel
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Mitochondria: In Sickness and in Health
2012 Standout
Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes
2015 StandoutNobel
Dynamic RNA Modifications in Gene Expression Regulation
2017 Standout
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
Metazoan MicroRNAs
2018 Standout
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Regulation of Hypoxia-Inducible Factor-1α, Vascular Endothelial Growth Factor, and Angiogenesis by an Insulin-Like Growth Factor-I Receptor Autocrine Loop in Human Pancreatic Cancer
2003 StandoutNobel
A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation
2015 StandoutNobel
Chemical remodelling of cell surfaces in living animals
2004 StandoutNatureNobel
Ageing and apoptosis
2002
3 ACAT Inhibitors: The Search for a Novel and Effective Treatment of Hypercholesterolemia and Atherosclerosis
2002
On the Dependency of Cellular Protein Levels on mRNA Abundance
2016 Standout
Chronic immune activation and inflammation in the pathogenesis of aids and cancer
2002
Selective activation of Akt1 by mammalian target of rapamycin complex 2 regulates cancer cell migration, invasion, and metastasis
2011
Malignant Gliomas in Adults
2008 Standout
Insulin, Insulin-Like Growth Factors and Colon Cancer: A Review of the Evidence
2001
Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults
1999 Standout
The cancerous translation apparatus
2011
The PtdIns(3,4)P2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death
2010 StandoutNatureNobel
AKT/PKB Signaling: Navigating the Network
2017 Standout
β-Arrestin and Mdm2 Mediate IGF-1 Receptor-stimulated ERK Activation and Cell Cycle Progression
2007 StandoutNobel
Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
2000
Lymphangiogenesis and lymphatic metastasis in breast cancer
2009
Reassessment of Exosome Composition
2019 Standout
Fibrinolysis, inflammation, and regulation of the plasminogen activating system
2007
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Obesity and the Metabolic Syndrome in Children and Adolescents
2004 Standout
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults
2003 Standout
Translational Activation of Snail1 and Other Developmentally Regulated Transcription Factors by YB-1 Promotes an Epithelial-Mesenchymal Transition
2009
eIF3d is an mRNA cap-binding protein that is required for specialized translation initiation
2016 StandoutNatureNobel
Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis.
2002
Targeted therapies in control of EMT in carcinoma and fibrosis
2007
Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States.
2001
Diabetes and Cancer
2010 Standout
Evolutionary Medicine: From Dwarf Model Systems to Healthy Centenarians?
2003 Science
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
ACAT2 Is Localized to Hepatocytes and Is the Major Cholesterol-Esterifying Enzyme in Human Liver
2004 StandoutNobel
Spermidine in health and disease
2018 StandoutScience
Enhancing the Efficacy of Drug-loaded Nanocarriers against Brain Tumors by Targeted Radiation Therapy
2013
Regulation and function of the RSK family of protein kinases
2011
Cancer Genome Landscapes
2013 StandoutScience
Integrin-linked kinase – essential roles in physiology and cancer biology
2008
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Carcinoma Cell Hyaluronan as a “Portable” Cancerized Prometastatic Microenvironment
2016
Preterm labor: One syndrome, many causes
2014 StandoutScience
Insulin-like Growth Factor II Signaling in Neoplastic Proliferation Is Blocked by Transgenic Expression of the Metalloproteinase Inhibitor Timp-1
1999
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Expression of insulin-like growth factor-1 receptor in synovial sarcoma: association with an aggressive phenotype.
1999
AKT activation up-regulates insulin-like growth factor-I receptor expression and promotes invasiveness of human pancreatic cancer cells
2001
Co-expression of MET and CD47 is a novel prognosticator for survival of luminal-type breast cancer patients
2014
Extending Healthy Life Span—From Yeast to Humans
2010 StandoutScience
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake
2003
Autophagy in Health and Disease: A Double-Edged Sword
2004 StandoutScience
Works of Sandra E. Dunn being referenced
Inhibition of Y-box binding protein-1 slows the growth of glioblastoma multiforme and sensitizes to temozolomide independent O 6-methylguanine-DNA methyltransferase
2009
Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival
2008
Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells
2008
Targeting tumour-initiating cells to improve the cure rates for triple-negative breast cancer
2010
Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells
2005
Celecoxib Inhibits Urokinase-Type Plasminogen Activator (uPA) Production in MDA-MB-231 Breast Cancer Cells
2005
The insulin-like growth factor-1 elevates urokinase-type plasminogen activator-1 in human breast cancer cells: A new avenue for breast cancer therapy
2000
Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy
2007
Hypocholesterolemic properties of plant indoles
1994
Insulin-like growth factor I stimulate angiogenesis and the production of vascular endothelial growth factor
2000
Insulin-Like Growth Factor-1 Inscribes a Gene Expression Profile for Angiogenic Factors and Cancer Progression in Breast Epithelial Cells
2002
Expression of the Insulin-Like Growth Factor I Receptor and Urokinase Plasminogen Activator in Breast Cancer Is Associated with Poor Survival
2004
Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer
2008
Preferential Dependence of Breast Cancer Cells versus Normal Cells on Integrin-Linked Kinase for Protein Kinase B/Akt Activation and Cell Survival
2006
Role of IGF-1R in Mediating Breast Cancer Invasion and Metastasis
2003
YB-1: oncoprotein, prognostic marker and therapeutic target?
2012
Genomic imbalance ofHMMR/RHAMMregulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition
2013
Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase.
2001
A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer.
1998
Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice.
1997
Molecular Profiling Identifies Prognostic Subgroups of Pediatric Glioblastoma and Shows Increased YB-1 Expression in Tumors
2007
Disulfiram, a drug widely used to control alcoholism, suppresses self-renewal of glioblastoma and overrides resistance to temozolomide
2012
Hierarchical Clustering Analysis of Tissue Microarray Immunostaining Data Identifies Prognostically Significant Groups of Breast Carcinoma
2004